Policy News

“Today, the US biotech industry employs nearly 2.3 million people across the US and is making positive contributions to economic impact and national security across all 50 states. In fact, for every dollar the National Institutes of Health (NIH) contributes to a successful drug, the private sector invests over $65, underscoring the agency’s unparalleled return…

One party control of the legislature and executive office came to end as an outcome of the November 2024 election. Republicans flipped enough seats to give them a 58-52 majority in the Michigan House for the next two-year term. In the Senate, the Democrats will hold only a one seat majority due a vacancy opening…

Federal Expectations: White House to Dictate, Congress Likely to Follow Following the Republican trifecta gain of the White House and both houses of the U.S. Congress, business leaders would be wise to spend early 2025 assessing how politics will drive policy.   At this early stage, it’s still unclear what and how policy issues will…

In an attempt to address high, out-of-pocket drug prices, Democrats attempted to push through several piece of legislation that would have placed burdensome restrictions on drug manufacturers. One measure, HB 5350, would have required drug manufacturers to provide drug products to contract pharmacies participating in a 340B program without conditions or limitations, and thereby alter…

The Michigan Senate passed the Personal Data Privacy Act (SB 659) along party lines in lame duck session, moving Michigan a step closer to joining the growing ranks of states that have approved comprehensive privacy and data protection legislation. But the legislation didn’t get taken up by the House and died, meaning that the measure…

Sen. Wojno introduced “Queenie’s Law,” Senate Bill 1019, to prohibit painful animal experiments.. The bill, a companion to legislation introduced in 2023 by Rep. Matt Koleszar (HB 4849) is a response to long- running, controversial dog studies conducted at Wayne State University. MichBio provided written testimony in opposition to the proposed legislation. After a substitution…

The newly constituted Michigan Rare Disease Advisory Council (MI RDAC) met in early October 2024 and began its mandate as an advisory body that provides Michigan’s rare disease community with a stronger voice in state government. The agenda included introductions of current panel members, an overview of pending legislation to enact an RDAC by statute,…

In a milestone for Michigan’s innovation economy, the legislature passed a long-awaited and long-fought Research & Development (R&D) Tax Credit legislation – fifteen years in the making! It was a protracted, and at times frustrating, journey for MichBio in its advocacy to reestablish an economic development incentive specifically aimed at R&D in Michigan. We watched…

This bipartisan legislation would enable millions of patients to receive quicker access to life- changing medical innovations. The legislation is designed to expedite the Medicare coverage determination process of breakthrough medical technologies for patients. Although the House of Representatives generated some momentum on related legislation, H.R. 1691, a Senate companion bill, S. 5349, the “Ensuring…